M&A Deal Summary |
|
---|---|
Date | 2022-09-12 |
Target | DISA |
Sector | Business Services |
Buyer(s) | Audax Private Equity |
Sellers(s) | Court Square Capital Partners |
Deal Type | Secondary Buyout |
Advisor(s) | Piper Sandler & Co. (Financial) Dechert (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1999 |
PE ASSETS | 19.0B USD |
Size | Mega |
Type | Sector Agnostic |
Audax Private Equity is a private equity firm focused on acquiring control positions in a variety of mid to large North American headquartered companies. The Firm segments its activities into lower middle-market and larger scale investing. Within its larger group, Audax targets profitable businesses valued up to $800 million and within its lower middle-market group, the Firm seeks companies valued up to $125 million. Sectors of interest include business services, consumer products/services, financial services, healthcare services, industrial services, software, and technology. Audax has a special interest in businesses that can benefit from a buy and build investment strategy for growth. Audax Private Equity was formed in 1999 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 158 of 168 |
Sector (Business Services) | 11 of 11 |
Type (Secondary Buyout) | 69 of 72 |
State (Texas) | 16 of 16 |
Country (United States) | 150 of 159 |
Year (2022) | 11 of 13 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-23 |
WellSpring Consumer Healthcare
Sarasota, Florida, United States WellSpring Consumer Healthcare is a marketer of over-the-counter and cosmetic brands in the skincare, feminine hygiene, and gastrointestinal care categories. WellSpring’s portfolio includes Bactine, Bonine, FDS, Emetrol, Micatin, Gelusil, Glaxal Base, Barriere, and K-Lyte. WellSpring Consumer Healthcare was founded in 1999 and is based in Sarasota, Florida. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-11-28 |
Medi-Weightloss
Tampa, Florida, United States Medi-Weightloss offers customized weight-loss programs designed to address obesity and other related diseases, including heart disease, stroke, type-2 diabetes, and other specific conditions generally covered by commercial insurance payors. The Company also sells a line of proprietary nutritional supplements, healthy-food products, and vitamins that treat comorbidities caused by obesity. Medi-Weightloss was formed in 2005 and is based in Tampa, Florida. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1968 |
PE ASSETS | 7.7B USD |
Size | Mega |
Type | Sector Agnostic |
Court Square Capital Partners (CSCP) is a generalist private equity firm that seeks middle market company investments across the US. CSCP looks to partner with management teams to accelerate revenue growth and improve operating efficiency. Sectors of interest include business services, building products, chemicals, consumer products, food products/services, healthcare, aerospace/defense, manufacturing, media, technology, telecommunications, and transportation. Court Square Capital Partners was formerly known as Citigroup Venture Capital Equity Partners. The Group spun out of Citigroup and became independent in 2006. CSCP is based in New York City.
DEAL STATS | # |
---|---|
Overall | 53 of 56 |
Sector (Business Services) | 4 of 4 |
Type (Secondary Buyout) | 17 of 18 |
State (Texas) | 6 of 6 |
Country (United States) | 50 of 53 |
Year (2022) | 3 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-07-11 |
West Coast Dental & Orthodontics
Los Angeles, California, United States West Coast Dental is a provider of multi-specialty dental and orthodontic care primarily servicing the Southern Californian market. Through its 40 state-of-the-art dental care practices across the state of California, it provides the highest standard of care to over 425,000 patient visits each year using the latest technologies with a team of talented general dentists and specialists. West Coast Dental was formed in 1991 and is based in Los Angeles, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-11-03 |
Celerion
Lincoln, Nebraska, United States Celerion is a clinical research organization that provides comprehensive clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe, and Asia. The Company serves its clients through a global network of facilities with a focus on applied translational medicine. Celerion was founded in 2010 and is based in Lincoln, Nebraska. |
Sell | - |